368 related articles for article (PubMed ID: 32371093)
21. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models.
Zhang Y; LaCerte C; Kansra S; Jackson JP; Brouwer KR; Edwards JE
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226620
[TBL] [Abstract][Full Text] [Related]
22. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
23. The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.
Verbeke L; Farre R; Verbinnen B; Covens K; Vanuytsel T; Verhaegen J; Komuta M; Roskams T; Chatterjee S; Annaert P; Vander Elst I; Windmolders P; Trebicka J; Nevens F; Laleman W
Am J Pathol; 2015 Feb; 185(2):409-19. PubMed ID: 25592258
[TBL] [Abstract][Full Text] [Related]
24. NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury.
Liu J; Liu J; Meng C; Gu Q; Huang C; Liu F; Xia C
Phytomedicine; 2023 Jan; 108():154529. PubMed ID: 36343550
[TBL] [Abstract][Full Text] [Related]
25. 3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism.
Stefela A; Kaspar M; Drastik M; Holas O; Hroch M; Smutny T; Skoda J; Hutníková M; Pandey AV; Micuda S; Kudova E; Pavek P
J Steroid Biochem Mol Biol; 2020 Sep; 202():105702. PubMed ID: 32505574
[TBL] [Abstract][Full Text] [Related]
26. Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
Yang H; Liu T; Wang J; Li TW; Fan W; Peng H; Krishnan A; Gores GJ; Mato JM; Lu SC
Hepatology; 2016 Aug; 64(2):439-55. PubMed ID: 26969892
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Zampella A; Monti MC; Scarpelli P; Ricci P; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1422-1437. PubMed ID: 31325638
[TBL] [Abstract][Full Text] [Related]
28. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.
Renga B; Mencarelli A; D'Amore C; Cipriani S; D'Auria MV; Sepe V; Chini MG; Monti MC; Bifulco G; Zampella A; Fiorucci S
PLoS One; 2012; 7(1):e30443. PubMed ID: 22291955
[TBL] [Abstract][Full Text] [Related]
29. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
[TBL] [Abstract][Full Text] [Related]
30. Targeting FXR in Cholestasis.
Keitel V; Dröge C; Häussinger D
Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
[TBL] [Abstract][Full Text] [Related]
31. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
[TBL] [Abstract][Full Text] [Related]
32. Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation.
Zhang DG; Zhang C; Wang JX; Wang BW; Wang H; Zhang ZH; Chen YH; Lu Y; Tao L; Wang JQ; Chen X; Xu DX
Toxicol Appl Pharmacol; 2017 Jan; 314():39-47. PubMed ID: 27865854
[TBL] [Abstract][Full Text] [Related]
33. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways.
Petrov PD; Soluyanova P; Sánchez-Campos S; Castell JV; Jover R
Food Chem Toxicol; 2021 Dec; 158():112664. PubMed ID: 34767876
[TBL] [Abstract][Full Text] [Related]
35. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
[TBL] [Abstract][Full Text] [Related]
36. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
[TBL] [Abstract][Full Text] [Related]
37. The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.
Attia YM; Tawfiq RA; Ali AA; Elmazar MM
Sci Rep; 2017 Oct; 7(1):12502. PubMed ID: 28970500
[TBL] [Abstract][Full Text] [Related]
38. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
39. [Study on protective effect of Chaihu Shugan Powder against liver injury in rats with intrahepatic cholestasis by regulating FXR/Nrf2/ARE pathway].
Lou J; Zhao L; Zhu YJ; Yuan SQ; Wang F; Zhang HZ; Xu JJ; Yu XK; Hou LF
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5610-5616. PubMed ID: 36471979
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation.
Weber AA; Mennillo E; Yang X; van der Schoor LWE; Jonker JW; Chen S; Tukey RH
Drug Metab Dispos; 2021 Jan; 49(1):12-19. PubMed ID: 33154041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
